Physician profile
Gregory R Lang
NPI 1023369527
$4,212.47
in general payments reported to CMS, 2019-2025
19 companies · $1,500 in 2025
The $1,500 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $509 · 2022: $500 · 2023: $1,006 · 2024: $698 · 2025: $1,500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,424 · Consulting Fee: $780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,423.94 |
| Consulting Fee | $780.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $1,016.33 | 2022-2025 | Nexletol, Nexlizet |
| Amgen INC. | $992.39 | 2021-2025 | Repatha |
| Novartis Pharmaceuticals Corporation | $413.72 | 2021-2025 | |
| Regeneron Pharmaceuticals, INC. | $372.06 | 2021-2023 | Evkeeza, Praluent |
| Novo Nordisk INC | $318.87 | 2024-2025 | Wegovy, Ozempic |
| Janssen Pharmaceuticals, INC | $236.24 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $157.53 | 2022-2024 | |
| Abbott Laboratories | $151.87 | 2022-2025 | Aveir |
| Ionis Pharmaceuticals, INC. | $107.28 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $98.97 | 2024-2025 | Camzyos, Eliquis |
| Regeneron Healthcare Solutions, INC. | $92.49 | 2025 | Evkeeza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.69 | 2024-2025 | Lifevest |
| Amarin Pharma, INC. | $51.31 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.90 | 2022-2025 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $35.28 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $25.25 | 2024 | Dexcom G6 Transmitter |
| Kestra Medical Technology Services, INC. | $17.47 | 2024 | Assure Wcd |
| United Therapeutics Corporation | $15.34 | 2024 | Tyvaso |
| Irhythm Technologies, INC. | $14.48 | 2024 | Zio Xt Patch, Zio Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Lang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.